GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MEDLEY Inc (TSE:4480) » Definitions » EV-to-EBITDA

MEDLEY (TSE:4480) EV-to-EBITDA : 26.57 (As of May. 05, 2024)


View and export this data going back to 2019. Start your Free Trial

What is MEDLEY EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MEDLEY's enterprise value is 円101,325 Mil. MEDLEY's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円3,813 Mil. Therefore, MEDLEY's EV-to-EBITDA for today is 26.57.

The historical rank and industry rank for MEDLEY's EV-to-EBITDA or its related term are showing as below:

TSE:4480' s EV-to-EBITDA Range Over the Past 10 Years
Min: 26.57   Med: 81.39   Max: 780.63
Current: 26.57

During the past 5 years, the highest EV-to-EBITDA of MEDLEY was 780.63. The lowest was 26.57. And the median was 81.39.

TSE:4480's EV-to-EBITDA is ranked worse than
81.3% of 460 companies
in the Healthcare Providers & Services industry
Industry Median: 13.06 vs TSE:4480: 26.57

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), MEDLEY's stock price is 円3555.00. MEDLEY's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円78.550. Therefore, MEDLEY's PE Ratio for today is 45.26.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


MEDLEY EV-to-EBITDA Historical Data

The historical data trend for MEDLEY's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDLEY EV-to-EBITDA Chart

MEDLEY Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
-154.94 225.02 52.92 54.36 28.79

MEDLEY Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.36 55.85 53.33 41.35 28.79

Competitive Comparison of MEDLEY's EV-to-EBITDA

For the Health Information Services subindustry, MEDLEY's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDLEY's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MEDLEY's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MEDLEY's EV-to-EBITDA falls into.



MEDLEY EV-to-EBITDA Calculation

MEDLEY's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=101324.924/3813
=26.57

MEDLEY's current Enterprise Value is 円101,325 Mil.
MEDLEY's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,813 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MEDLEY  (TSE:4480) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

MEDLEY's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3555.00/78.550
=45.26

MEDLEY's share price for today is 円3555.00.
MEDLEY's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円78.550.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


MEDLEY EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MEDLEY's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


MEDLEY (TSE:4480) Business Description

Traded in Other Exchanges
Address
3-2-1 Roppongi, Minato-ku, 22nd Floor Sumitomo Fudosan Roppongi Grand Tower, Tokyo, JPN, 106-6222
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.

MEDLEY (TSE:4480) Headlines

No Headlines